CPWM
ABBV icon

Cypress Point Wealth Management’s AbbVie ABBV Stock Holding History

Cypress Point Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Buy
2,055
+940
+84% +$202K 0.11% 76
2026
Q1 		$243K Buy
+1,115
New +$247K 0.05% 106

Other funds holding ABBV

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Cypress Point Wealth Management's ABBV Position: Q2 2026 in Review

Cypress Point Wealth Management increased its AbbVie (ABBV) stake by 84% in Q2 2026, buying an estimated $202K and bringing the position to 2,055 shares worth $517K. The position accounts for 0.11% of the portfolio, ranked #76.

Cypress Point Wealth Management first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 2,287 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cypress Point Wealth Management held 2,055 shares of AbbVie worth $517K as of Q2 2026.
  • Cypress Point Wealth Management bought 940 AbbVie shares in Q2 2026, an estimated $202K.
  • AbbVie made up 0.11% of Cypress Point Wealth Management's portfolio in Q2 2026, its #76 holding.
  • Cypress Point Wealth Management first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • 2,287 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cypress Point Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.